HDAC9 and cancer: So, once achievedmetabolic stability and selectivity among HDACs, the new hydrazide-basedHDACi showed lesser off-target effects and a good selectivity amongHDACs, thus offering a promising therapeutic potential in cancer andother disease treatments, even paving the way to extended clinicalapplications of HDAC inhibitors.,